Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Vitamin D

Henry J Woodford
Download PDF
DOI: https://doi.org/10.7861/clinmed.Let.21.1.7
Clin Med January 2021
Henry J Woodford
Northumbria Healthcare NHS Foundation Trust, UK
Roles: Consultant geriatrician
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Editor – In their recent article, Griffin et al suggest that all adults should receive 800–1,000 IU vitamin D daily supplementation, perhaps to reduce the impact of the COVID-19 pandemic.1 They point to an observed association between low serum 25-hydroxyvitamin D (25(OH)D) concentration and COVID-19 seropositivity in a recent study involving two of the current article's authors.2 In addition, they highlight a small, open label, pilot study from Spain (n=76), which suggested a lower rate of intensive care unit admission with vitamin D supplementation compared with placebo (baseline and on-treatment 25(OH)D concentrations not reported).3

There is a familiar tale of vitamin D that has been repeated over the last few decades. Observational studies associate low serum 25(OH)D with numerous adverse health outcomes.4,5 Yet despite tens of thousands of people being randomised into studies, the evidence for any health benefit from vitamin D supplementation still evades us.6–7 The reason for the association of low 25(OH)D and adverse outcomes is multifactorial; in part related to people with poorer health status getting less sunlight exposure and having reduced dietary intake; in part due to the negative acute phase response of serum 25(OH)D (ie it is lowered in times of bodily inflammation).8

Through the majority of their article, Griffin et al consider the serum concentration at which 25(OH)D would justify supplementation. The argument for a higher threshold (50 nmol/L) being mainly supported by the observation that elevating serum 25(OH)D concentration suppresses parathyroid hormone release. But does this lead to any tangible health benefits?

There is some evidence that only 25(OH)D concentrations of 10 nmol/L or below create significant biochemical disorders, such as hypocalcaemia.9 Improved bone health has been examined as a potential major benefit of vitamin D supplementation. A study that randomised 2,578 people aged over 70 years (mean age 80) compared vitamin D supplementation with placebo over a median follow-up of 3.5 years.10 Despite higher serum 25(OH)D concentrations achieved with supplementation (60 nmol/L vs 23 nmol/L), no reduction in fracture rate was detected. These data do not support accepting <50 nmol/L as the threshold for 25(OH)D deficiency.

In any case, Griffin et al are not advocating a treat-to-target approach, instead a blanket supplementation for all adults. Although the risk of harm may be small, adverse effects would include some gastrointestinal symptoms and occasional cases of hypercalcaemia.7 Additional tablets would contribute to the growing burden of polypharmacy for many people. But perhaps most importantly, what would be the opportunity cost? Instead of using resources putting unwanted and unopened boxes of pills in every home in Britain and Ireland, we could be investing in shared decision-making processes to encourage health improvement for individuals under our care. Promoting non-pharmacological approaches, including smoking cessation and exercising outdoors, would have a far greater impact on our nations’ well-being.

  • © Royal College of Physicians 2021. All rights reserved.

References

  1. ↵
    1. Griffin G
    , Hewison M, Hopkin J, et al. Preventing vitamin D deficiency during the COVID-19 pandemic: UK definitions of vitamin D sufficiency and recommended supplement dose are set too low. Clin Med 2021;21:e48–51.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Faniyi AA
    , Lugg ST, Faustini SE, et al. Vitamin D status and seroconversion for COVID-19 in UK healthcare workers who isolated for COVID-19 like symptoms during the 2020 pandemic. medRxiv 2020.10.05.20206706.
  3. ↵
    1. Castillo ME
    , Entrenas Costa LM, Vaquero Barrios JM, et al. Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study. J Steroid Biochem Mol Biol 2020;203:105751.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Schottker B
    , Jorde R, Peasey AS, et al. Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ 2014;348:g3656.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Bolland MJ
    , Avenell A, Grey A. Should adults take vitamin D supplements to prevent disease? BMJ 2016;355:i6201.
    OpenUrlFREE Full Text
  6. ↵
    1. Theodoratou E
    , Tzoulaki I, Zgaga L, et al. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 2014;348:g2035.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Avenell A
    , Mak JCS, O’Connell D. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev 2014;2014:CD000227.
    OpenUrl
  8. ↵
    1. Waldron JL
    , Ashby HL, Cornes MP, et al. Vitamin D: a negative acute phase reactant. J Clin Pathol 2013;66:620–2.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Need AG
    , O’Loughlin PD, Morris HA, et al. Vitamin D metabolites and calcium absorption in severe vitamin D deficiency. J Bone Miner Res 2008;23:1859–63.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Lips P
    , Graafmans W, Ooms M, et al. Vitamin D supplementation and fracture incidence in elderly persons: a randomized, placebo-controlled clinical trial. Ann Intern Med 1996;124:400–6.
    OpenUrlCrossRefPubMed
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Vitamin D
Henry J Woodford
Clinical Medicine Jan 2021, 21 (1) e119-e120; DOI: 10.7861/clinmed.Let.21.1.7

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Vitamin D
Henry J Woodford
Clinical Medicine Jan 2021, 21 (1) e119-e120; DOI: 10.7861/clinmed.Let.21.1.7
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • References
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The association of pleural effusion and pulmonary embolism
  • What is the impact of COVID-19 on complaints against doctors?
  • The significance of the gut microbiome in post-COVID-19 gastrointestinal symptoms
Show more Letters to the editor

Similar Articles

FAQs

  • Difficulty logging in.

There is currently no login required to access the journals. Please go to the home page and simply click on the edition that you wish to read. If you are still unable to access the content you require, please let us know through the 'Contact us' page.

  • Can't find the CME questionnaire.

The read-only self-assessment questionnaire (SAQ) can be found after the CME section in each edition of Clinical Medicine. RCP members and fellows (using their login details for the main RCP website) are able to access the full SAQ with answers and are awarded 2 CPD points upon successful (8/10) completion from:  https://cme.rcplondon.ac.uk

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians